COJOCARU S, РУСУ И, BUTA G, BERSAN S, POTÎNG-RAȘCOV V, CULIUC N, BABA L. A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Интернет]. 29 июнь 2023 г. [цитируется по 20 май 2024 г.];4(4):19-6. доступно на: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374